Hayley Gershengorn
@hbgmd.bsky.social
ICU doctor & health services researcher living in Miami, FL. Inaugural Editor-in-Chief of CHEST Critical Care. All views my own.
😵💫 Heterogeneity of treatment effect is sometimes unexpected…
✅ out A Khan et al’s work looking at how the following interact for sepsis patients:
✴️ balanced IVFs vs 0.9% saline &
✴️ liberal vs restrictive fluid rx
www.chestcc.org/article/S294...
#journal_CHESTCritCare
@accpchest.bsky.social
✅ out A Khan et al’s work looking at how the following interact for sepsis patients:
✴️ balanced IVFs vs 0.9% saline &
✴️ liberal vs restrictive fluid rx
www.chestcc.org/article/S294...
#journal_CHESTCritCare
@accpchest.bsky.social
November 18, 2025 at 10:24 PM
😵💫 Heterogeneity of treatment effect is sometimes unexpected…
✅ out A Khan et al’s work looking at how the following interact for sepsis patients:
✴️ balanced IVFs vs 0.9% saline &
✴️ liberal vs restrictive fluid rx
www.chestcc.org/article/S294...
#journal_CHESTCritCare
@accpchest.bsky.social
✅ out A Khan et al’s work looking at how the following interact for sepsis patients:
✴️ balanced IVFs vs 0.9% saline &
✴️ liberal vs restrictive fluid rx
www.chestcc.org/article/S294...
#journal_CHESTCritCare
@accpchest.bsky.social
🤷♀️ how can we study something we can’t even define⁉️
In #journal_CHESTCritCare, Jolink et al describe the many names we have for prolonged ARDS…
www.chestcc.org/article/S294...
…prolonged…
…non-resolving…
…late…
…
…
@accpchest.bsky.social
In #journal_CHESTCritCare, Jolink et al describe the many names we have for prolonged ARDS…
www.chestcc.org/article/S294...
…prolonged…
…non-resolving…
…late…
…
…
@accpchest.bsky.social
November 18, 2025 at 12:59 AM
🤷♀️ how can we study something we can’t even define⁉️
In #journal_CHESTCritCare, Jolink et al describe the many names we have for prolonged ARDS…
www.chestcc.org/article/S294...
…prolonged…
…non-resolving…
…late…
…
…
@accpchest.bsky.social
In #journal_CHESTCritCare, Jolink et al describe the many names we have for prolonged ARDS…
www.chestcc.org/article/S294...
…prolonged…
…non-resolving…
…late…
…
…
@accpchest.bsky.social
🙄 Do intensivists ever agree on anything?
Peter Nauka & colleagues 👀 at variability in how we approach respiratory support for ICU patients:
www.chestcc.org/article/S294...
🫣 SPOILER ALERT: nope, we don’t agree
Happy 👻🎃 from #journal_CHESTCritCare!
@seymoc.bsky.social
@accpchest.bsky.social
Peter Nauka & colleagues 👀 at variability in how we approach respiratory support for ICU patients:
www.chestcc.org/article/S294...
🫣 SPOILER ALERT: nope, we don’t agree
Happy 👻🎃 from #journal_CHESTCritCare!
@seymoc.bsky.social
@accpchest.bsky.social
October 31, 2025 at 8:54 PM
🙄 Do intensivists ever agree on anything?
Peter Nauka & colleagues 👀 at variability in how we approach respiratory support for ICU patients:
www.chestcc.org/article/S294...
🫣 SPOILER ALERT: nope, we don’t agree
Happy 👻🎃 from #journal_CHESTCritCare!
@seymoc.bsky.social
@accpchest.bsky.social
Peter Nauka & colleagues 👀 at variability in how we approach respiratory support for ICU patients:
www.chestcc.org/article/S294...
🫣 SPOILER ALERT: nope, we don’t agree
Happy 👻🎃 from #journal_CHESTCritCare!
@seymoc.bsky.social
@accpchest.bsky.social
🤞 Ever wish we had a tool to accurately predict HFNC failure? 🛠️
J Taylor & colleagues look at ROX…
www.chestcc.org/article/S294...
✳️ SPOILER ALERT ✳️
… it seems to “work” 😊
#journal_CHESTCritCare
#OpenAccess
@accpchest.bsky.social
J Taylor & colleagues look at ROX…
www.chestcc.org/article/S294...
✳️ SPOILER ALERT ✳️
… it seems to “work” 😊
#journal_CHESTCritCare
#OpenAccess
@accpchest.bsky.social
October 10, 2025 at 10:41 AM
🤞 Ever wish we had a tool to accurately predict HFNC failure? 🛠️
J Taylor & colleagues look at ROX…
www.chestcc.org/article/S294...
✳️ SPOILER ALERT ✳️
… it seems to “work” 😊
#journal_CHESTCritCare
#OpenAccess
@accpchest.bsky.social
J Taylor & colleagues look at ROX…
www.chestcc.org/article/S294...
✳️ SPOILER ALERT ✳️
… it seems to “work” 😊
#journal_CHESTCritCare
#OpenAccess
@accpchest.bsky.social
☔️ It’s raining #journal_CHESTCritCare research!
Out today, 🥉 studies to:
*️⃣ eval processes to support surrogate decision makers
*️⃣ assess use of lactate clearance in post-op ♥️ surgery
*️⃣ compare exposure & outcomes across opioid drugs in ARF
All at:
chestcc.org
@accpchest.bsky.social
Out today, 🥉 studies to:
*️⃣ eval processes to support surrogate decision makers
*️⃣ assess use of lactate clearance in post-op ♥️ surgery
*️⃣ compare exposure & outcomes across opioid drugs in ARF
All at:
chestcc.org
@accpchest.bsky.social
October 7, 2025 at 10:24 PM
☔️ It’s raining #journal_CHESTCritCare research!
Out today, 🥉 studies to:
*️⃣ eval processes to support surrogate decision makers
*️⃣ assess use of lactate clearance in post-op ♥️ surgery
*️⃣ compare exposure & outcomes across opioid drugs in ARF
All at:
chestcc.org
@accpchest.bsky.social
Out today, 🥉 studies to:
*️⃣ eval processes to support surrogate decision makers
*️⃣ assess use of lactate clearance in post-op ♥️ surgery
*️⃣ compare exposure & outcomes across opioid drugs in ARF
All at:
chestcc.org
@accpchest.bsky.social
It’s back! …#journal_CHESTCritCare’s A.T.L.A.S. 🗺️
@annajanas.bsky.social & colleagues from ⭐️Around The Land and Across Specialties⭐️ discuss how the “Oxy-PICU” trial impacts their care:
www.chestcc.org/article/S294...
To learn about the ATLAS series:
www.chestcc.org/article/S294...
#OpenAccess
@annajanas.bsky.social & colleagues from ⭐️Around The Land and Across Specialties⭐️ discuss how the “Oxy-PICU” trial impacts their care:
www.chestcc.org/article/S294...
To learn about the ATLAS series:
www.chestcc.org/article/S294...
#OpenAccess
October 2, 2025 at 12:08 PM
It’s back! …#journal_CHESTCritCare’s A.T.L.A.S. 🗺️
@annajanas.bsky.social & colleagues from ⭐️Around The Land and Across Specialties⭐️ discuss how the “Oxy-PICU” trial impacts their care:
www.chestcc.org/article/S294...
To learn about the ATLAS series:
www.chestcc.org/article/S294...
#OpenAccess
@annajanas.bsky.social & colleagues from ⭐️Around The Land and Across Specialties⭐️ discuss how the “Oxy-PICU” trial impacts their care:
www.chestcc.org/article/S294...
To learn about the ATLAS series:
www.chestcc.org/article/S294...
#OpenAccess
🏃♀️ I try so hard to keep up…
…but sometimes it’s just too much!
#journal_CHESTCritCare had 3 new pubs today & there’s something for everyone:
1️⃣ editorial (re iNO)
1️⃣ review (re AI)
1️⃣ study (re EOL care)
✅ them out… all #OpenAccess:
www.chestcc.org
@accpchest.bsky.social
…but sometimes it’s just too much!
#journal_CHESTCritCare had 3 new pubs today & there’s something for everyone:
1️⃣ editorial (re iNO)
1️⃣ review (re AI)
1️⃣ study (re EOL care)
✅ them out… all #OpenAccess:
www.chestcc.org
@accpchest.bsky.social
September 30, 2025 at 12:04 PM
🏃♀️ I try so hard to keep up…
…but sometimes it’s just too much!
#journal_CHESTCritCare had 3 new pubs today & there’s something for everyone:
1️⃣ editorial (re iNO)
1️⃣ review (re AI)
1️⃣ study (re EOL care)
✅ them out… all #OpenAccess:
www.chestcc.org
@accpchest.bsky.social
…but sometimes it’s just too much!
#journal_CHESTCritCare had 3 new pubs today & there’s something for everyone:
1️⃣ editorial (re iNO)
1️⃣ review (re AI)
1️⃣ study (re EOL care)
✅ them out… all #OpenAccess:
www.chestcc.org
@accpchest.bsky.social
🧩+🧩? …ever thought to add immunomodulators together?
A Shorr & colleagues 👀 at vilobelimab added to others in COVID, just out in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
Could this stacked approach have value in other viral pneumonia?
@accpchest.bsky.social
A Shorr & colleagues 👀 at vilobelimab added to others in COVID, just out in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
Could this stacked approach have value in other viral pneumonia?
@accpchest.bsky.social
September 30, 2025 at 11:51 AM
🧩+🧩? …ever thought to add immunomodulators together?
A Shorr & colleagues 👀 at vilobelimab added to others in COVID, just out in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
Could this stacked approach have value in other viral pneumonia?
@accpchest.bsky.social
A Shorr & colleagues 👀 at vilobelimab added to others in COVID, just out in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
Could this stacked approach have value in other viral pneumonia?
@accpchest.bsky.social
I ❤️ numbers in the ICU… but what if they aren’t accurate?
@mdspraider.bsky.social et al evaluated whether the airway pressures we see on ventilators 🟰 the tracheal P during iMV…
✴️ SPOILER ALERT ✴️ …nope!
www.chestcc.org/article/S294...
✔️ it out in #journal_CHESTCritCare
@accpchest.bsky.social
@mdspraider.bsky.social et al evaluated whether the airway pressures we see on ventilators 🟰 the tracheal P during iMV…
✴️ SPOILER ALERT ✴️ …nope!
www.chestcc.org/article/S294...
✔️ it out in #journal_CHESTCritCare
@accpchest.bsky.social
September 25, 2025 at 12:17 AM
I ❤️ numbers in the ICU… but what if they aren’t accurate?
@mdspraider.bsky.social et al evaluated whether the airway pressures we see on ventilators 🟰 the tracheal P during iMV…
✴️ SPOILER ALERT ✴️ …nope!
www.chestcc.org/article/S294...
✔️ it out in #journal_CHESTCritCare
@accpchest.bsky.social
@mdspraider.bsky.social et al evaluated whether the airway pressures we see on ventilators 🟰 the tracheal P during iMV…
✴️ SPOILER ALERT ✴️ …nope!
www.chestcc.org/article/S294...
✔️ it out in #journal_CHESTCritCare
@accpchest.bsky.social
💰…🤕 Curious about the interplay of financial hardship & ICU patient outcomes❓
Just out in #journal_CHESTCritCare, Uyeda & colleagues look at:
1️⃣ risk factors of $ hardship &
2️⃣ association of hardship w outcomes:
www.chestcc.org/article/S294...
@accpchest.bsky.social
Just out in #journal_CHESTCritCare, Uyeda & colleagues look at:
1️⃣ risk factors of $ hardship &
2️⃣ association of hardship w outcomes:
www.chestcc.org/article/S294...
@accpchest.bsky.social
September 25, 2025 at 12:03 AM
💰…🤕 Curious about the interplay of financial hardship & ICU patient outcomes❓
Just out in #journal_CHESTCritCare, Uyeda & colleagues look at:
1️⃣ risk factors of $ hardship &
2️⃣ association of hardship w outcomes:
www.chestcc.org/article/S294...
@accpchest.bsky.social
Just out in #journal_CHESTCritCare, Uyeda & colleagues look at:
1️⃣ risk factors of $ hardship &
2️⃣ association of hardship w outcomes:
www.chestcc.org/article/S294...
@accpchest.bsky.social
🩻 ARDS occurs in trauma… but what about spinal cord injury specifically?
Just out in #journal_CHESTCritCare, Lozano & colleagues learn:
➡️ how often?
➡️ in whom?
www.chestcc.org/article/S294...
@accpchest.bsky.social
Just out in #journal_CHESTCritCare, Lozano & colleagues learn:
➡️ how often?
➡️ in whom?
www.chestcc.org/article/S294...
@accpchest.bsky.social
September 14, 2025 at 1:22 PM
🩻 ARDS occurs in trauma… but what about spinal cord injury specifically?
Just out in #journal_CHESTCritCare, Lozano & colleagues learn:
➡️ how often?
➡️ in whom?
www.chestcc.org/article/S294...
@accpchest.bsky.social
Just out in #journal_CHESTCritCare, Lozano & colleagues learn:
➡️ how often?
➡️ in whom?
www.chestcc.org/article/S294...
@accpchest.bsky.social
Is there a “just right” reintubation rate? 🐻
Arita et al explore the association of reintub rate w outcomes, just released in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
I was surprised by their findings 😳
@accpchest.bsky.social
Arita et al explore the association of reintub rate w outcomes, just released in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
I was surprised by their findings 😳
@accpchest.bsky.social
September 14, 2025 at 1:10 PM
Is there a “just right” reintubation rate? 🐻
Arita et al explore the association of reintub rate w outcomes, just released in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
I was surprised by their findings 😳
@accpchest.bsky.social
Arita et al explore the association of reintub rate w outcomes, just released in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
I was surprised by their findings 😳
@accpchest.bsky.social
🎁 It’s here… & it’s bigger than ever…
#journal_CHESTCritCare, vol 3, iss 3 is out!
www.chestcc.org/current
✳️ 15 res articles
✳️ 1 review
✳️ 1 special feature
✳️ 1 US corner case series
✳️ 7 editorials
✳️ 3 letters
It’s #OpenAccess, so what’s your excuse to not look? 👀
@accpchest.bsky.social
#journal_CHESTCritCare, vol 3, iss 3 is out!
www.chestcc.org/current
✳️ 15 res articles
✳️ 1 review
✳️ 1 special feature
✳️ 1 US corner case series
✳️ 7 editorials
✳️ 3 letters
It’s #OpenAccess, so what’s your excuse to not look? 👀
@accpchest.bsky.social
September 12, 2025 at 11:43 AM
🎁 It’s here… & it’s bigger than ever…
#journal_CHESTCritCare, vol 3, iss 3 is out!
www.chestcc.org/current
✳️ 15 res articles
✳️ 1 review
✳️ 1 special feature
✳️ 1 US corner case series
✳️ 7 editorials
✳️ 3 letters
It’s #OpenAccess, so what’s your excuse to not look? 👀
@accpchest.bsky.social
#journal_CHESTCritCare, vol 3, iss 3 is out!
www.chestcc.org/current
✳️ 15 res articles
✳️ 1 review
✳️ 1 special feature
✳️ 1 US corner case series
✳️ 7 editorials
✳️ 3 letters
It’s #OpenAccess, so what’s your excuse to not look? 👀
@accpchest.bsky.social
🤔 Ever wonder if our ICU families experience trauma? Esp those w a trauma history?
D Ashana & colleagues 👀 at just that thru interviews w 26 family members, just out in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
#OpenAccess
@joannahart.bsky.social
@accpchest.bsky.social
D Ashana & colleagues 👀 at just that thru interviews w 26 family members, just out in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
#OpenAccess
@joannahart.bsky.social
@accpchest.bsky.social
September 10, 2025 at 6:29 PM
🤔 Ever wonder if our ICU families experience trauma? Esp those w a trauma history?
D Ashana & colleagues 👀 at just that thru interviews w 26 family members, just out in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
#OpenAccess
@joannahart.bsky.social
@accpchest.bsky.social
D Ashana & colleagues 👀 at just that thru interviews w 26 family members, just out in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
#OpenAccess
@joannahart.bsky.social
@accpchest.bsky.social
SpO2 👆 is better vs SaO2 🩸, bc it’s noninvasive…
…but it must be accurate for all 🧒🏽👩🏼👨🏿… & it hasn’t been ☹️
Just out in #journal_CHESTCritCare, Travers et al report the pilot results of a prosp study w skin tone:
www.chestcc.org/article/S294...
@accpchest.bsky.social
@andrewgoodwin.bsky.social
…but it must be accurate for all 🧒🏽👩🏼👨🏿… & it hasn’t been ☹️
Just out in #journal_CHESTCritCare, Travers et al report the pilot results of a prosp study w skin tone:
www.chestcc.org/article/S294...
@accpchest.bsky.social
@andrewgoodwin.bsky.social
September 10, 2025 at 6:11 PM
SpO2 👆 is better vs SaO2 🩸, bc it’s noninvasive…
…but it must be accurate for all 🧒🏽👩🏼👨🏿… & it hasn’t been ☹️
Just out in #journal_CHESTCritCare, Travers et al report the pilot results of a prosp study w skin tone:
www.chestcc.org/article/S294...
@accpchest.bsky.social
@andrewgoodwin.bsky.social
…but it must be accurate for all 🧒🏽👩🏼👨🏿… & it hasn’t been ☹️
Just out in #journal_CHESTCritCare, Travers et al report the pilot results of a prosp study w skin tone:
www.chestcc.org/article/S294...
@accpchest.bsky.social
@andrewgoodwin.bsky.social
💭 What’s the right steroid & dose for ARDS? 🩻
…dexamethasone, hydrocortisone, or methylprednisolone… 💉
Imai & colleagues perform a 🌟network meta-analysis🌟 in COVID & non-COVID patients, just out in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
@accpchest.bsky.social
…dexamethasone, hydrocortisone, or methylprednisolone… 💉
Imai & colleagues perform a 🌟network meta-analysis🌟 in COVID & non-COVID patients, just out in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
@accpchest.bsky.social
September 3, 2025 at 12:24 AM
💭 What’s the right steroid & dose for ARDS? 🩻
…dexamethasone, hydrocortisone, or methylprednisolone… 💉
Imai & colleagues perform a 🌟network meta-analysis🌟 in COVID & non-COVID patients, just out in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
@accpchest.bsky.social
…dexamethasone, hydrocortisone, or methylprednisolone… 💉
Imai & colleagues perform a 🌟network meta-analysis🌟 in COVID & non-COVID patients, just out in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
@accpchest.bsky.social
❓ Are you a lumper or a splitter… or a transporter?
Flick & colleagues query whether sepsis survivor subtypes are 🚀transportable🚀 to ARDS survivors, just out in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
@tvalley.bsky.social
@iwashyna.bsky.social
@accpchest.bsky.social
Flick & colleagues query whether sepsis survivor subtypes are 🚀transportable🚀 to ARDS survivors, just out in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
@tvalley.bsky.social
@iwashyna.bsky.social
@accpchest.bsky.social
August 26, 2025 at 10:56 AM
❓ Are you a lumper or a splitter… or a transporter?
Flick & colleagues query whether sepsis survivor subtypes are 🚀transportable🚀 to ARDS survivors, just out in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
@tvalley.bsky.social
@iwashyna.bsky.social
@accpchest.bsky.social
Flick & colleagues query whether sepsis survivor subtypes are 🚀transportable🚀 to ARDS survivors, just out in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
@tvalley.bsky.social
@iwashyna.bsky.social
@accpchest.bsky.social
It’s a real gift 🎁, to be able to give a dying person a comfortable death…
…but: What if we fail? What if they’re in pain/distress? 😩🫨
Just out in #journal_CHESTCritCare, Fehnel et al look at how often this happens:
www.chestcc.org/article/S294...
👀, it’s #OpenAccess!
@accpchest.bsky.social
…but: What if we fail? What if they’re in pain/distress? 😩🫨
Just out in #journal_CHESTCritCare, Fehnel et al look at how often this happens:
www.chestcc.org/article/S294...
👀, it’s #OpenAccess!
@accpchest.bsky.social
August 24, 2025 at 3:43 PM
It’s a real gift 🎁, to be able to give a dying person a comfortable death…
…but: What if we fail? What if they’re in pain/distress? 😩🫨
Just out in #journal_CHESTCritCare, Fehnel et al look at how often this happens:
www.chestcc.org/article/S294...
👀, it’s #OpenAccess!
@accpchest.bsky.social
…but: What if we fail? What if they’re in pain/distress? 😩🫨
Just out in #journal_CHESTCritCare, Fehnel et al look at how often this happens:
www.chestcc.org/article/S294...
👀, it’s #OpenAccess!
@accpchest.bsky.social
🧐 Ever wonder what happens to the patients who don’t get a requested VV-ECMO cannulation? 🫁
Just out in #journal_CHESTCritCare, Dinh & colleagues show us…
www.chestcc.org/article/S294...
#OpenAccess
@accpchest.bsky.social
Just out in #journal_CHESTCritCare, Dinh & colleagues show us…
www.chestcc.org/article/S294...
#OpenAccess
@accpchest.bsky.social
August 24, 2025 at 3:22 PM
🧐 Ever wonder what happens to the patients who don’t get a requested VV-ECMO cannulation? 🫁
Just out in #journal_CHESTCritCare, Dinh & colleagues show us…
www.chestcc.org/article/S294...
#OpenAccess
@accpchest.bsky.social
Just out in #journal_CHESTCritCare, Dinh & colleagues show us…
www.chestcc.org/article/S294...
#OpenAccess
@accpchest.bsky.social
❓ What does iNO do in the setting of COVID pneumonia? 🫁
Does it differ by respiratory support modality?
T Ramaswamy & colleagues explore these ?s:
www.chestcc.org/article/S294...
#journal_CHESTCritCare is all #OpenAccess!
@accpchest.bsky.social
Does it differ by respiratory support modality?
T Ramaswamy & colleagues explore these ?s:
www.chestcc.org/article/S294...
#journal_CHESTCritCare is all #OpenAccess!
@accpchest.bsky.social
August 6, 2025 at 10:01 PM
❓ What does iNO do in the setting of COVID pneumonia? 🫁
Does it differ by respiratory support modality?
T Ramaswamy & colleagues explore these ?s:
www.chestcc.org/article/S294...
#journal_CHESTCritCare is all #OpenAccess!
@accpchest.bsky.social
Does it differ by respiratory support modality?
T Ramaswamy & colleagues explore these ?s:
www.chestcc.org/article/S294...
#journal_CHESTCritCare is all #OpenAccess!
@accpchest.bsky.social
Sometimes we need to consider unexpected tools 🛠️…
Just out in #journal_CHESTCritCare, Auld & colleagues 👀 at cyproheptadine for COVID as part of the I-SPY platform 🕵️♂️:
www.chestcc.org/article/S294...
Learn about the adaptive platform trial infrastructure (#OpenAccess)
@accpchest.bsky.social
Just out in #journal_CHESTCritCare, Auld & colleagues 👀 at cyproheptadine for COVID as part of the I-SPY platform 🕵️♂️:
www.chestcc.org/article/S294...
Learn about the adaptive platform trial infrastructure (#OpenAccess)
@accpchest.bsky.social
August 6, 2025 at 9:50 PM
Sometimes we need to consider unexpected tools 🛠️…
Just out in #journal_CHESTCritCare, Auld & colleagues 👀 at cyproheptadine for COVID as part of the I-SPY platform 🕵️♂️:
www.chestcc.org/article/S294...
Learn about the adaptive platform trial infrastructure (#OpenAccess)
@accpchest.bsky.social
Just out in #journal_CHESTCritCare, Auld & colleagues 👀 at cyproheptadine for COVID as part of the I-SPY platform 🕵️♂️:
www.chestcc.org/article/S294...
Learn about the adaptive platform trial infrastructure (#OpenAccess)
@accpchest.bsky.social
💭 Remember when adult ECMO was so new we had no data to guide us?
Times r changing!
Just out in #journal_CHESTCritCare, Kazama et al outline a trial for AC targets in VA-ECMO:
www.chestcc.org/article/S294...
Not an ECMO guru? It’s still worth a 👀 to learn Win Ratios!
@accpchest.bsky.social
Times r changing!
Just out in #journal_CHESTCritCare, Kazama et al outline a trial for AC targets in VA-ECMO:
www.chestcc.org/article/S294...
Not an ECMO guru? It’s still worth a 👀 to learn Win Ratios!
@accpchest.bsky.social
July 22, 2025 at 12:07 PM
💭 Remember when adult ECMO was so new we had no data to guide us?
Times r changing!
Just out in #journal_CHESTCritCare, Kazama et al outline a trial for AC targets in VA-ECMO:
www.chestcc.org/article/S294...
Not an ECMO guru? It’s still worth a 👀 to learn Win Ratios!
@accpchest.bsky.social
Times r changing!
Just out in #journal_CHESTCritCare, Kazama et al outline a trial for AC targets in VA-ECMO:
www.chestcc.org/article/S294...
Not an ECMO guru? It’s still worth a 👀 to learn Win Ratios!
@accpchest.bsky.social
📖 A Tale of Two Strategies: CVCs vs pIVs for vasopressor administration 💉
Just out in #journal_CHESTCritCare, Lara Groetzinger et al show us the impact of their peripheral VP policy in the MICU ⭐️vs other ICUs⭐️ at their site:
www.chestcc.org/article/S294...
@accpchest.bsky.social
Just out in #journal_CHESTCritCare, Lara Groetzinger et al show us the impact of their peripheral VP policy in the MICU ⭐️vs other ICUs⭐️ at their site:
www.chestcc.org/article/S294...
@accpchest.bsky.social
July 21, 2025 at 7:57 PM
📖 A Tale of Two Strategies: CVCs vs pIVs for vasopressor administration 💉
Just out in #journal_CHESTCritCare, Lara Groetzinger et al show us the impact of their peripheral VP policy in the MICU ⭐️vs other ICUs⭐️ at their site:
www.chestcc.org/article/S294...
@accpchest.bsky.social
Just out in #journal_CHESTCritCare, Lara Groetzinger et al show us the impact of their peripheral VP policy in the MICU ⭐️vs other ICUs⭐️ at their site:
www.chestcc.org/article/S294...
@accpchest.bsky.social
There’s lots of heterogeneity of thought 🧠 re: whether to use paralytics in ARDS 🩻…
Might this be bc of heterogeneity of treatment effect?
A Duggal et al take a 👀 just out today in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
@accpchest.bsky.social
Might this be bc of heterogeneity of treatment effect?
A Duggal et al take a 👀 just out today in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
@accpchest.bsky.social
July 21, 2025 at 7:31 PM
There’s lots of heterogeneity of thought 🧠 re: whether to use paralytics in ARDS 🩻…
Might this be bc of heterogeneity of treatment effect?
A Duggal et al take a 👀 just out today in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
@accpchest.bsky.social
Might this be bc of heterogeneity of treatment effect?
A Duggal et al take a 👀 just out today in #journal_CHESTCritCare:
www.chestcc.org/article/S294...
@accpchest.bsky.social
Both delirium 😵💫 & frailty 🚫💪 are important predictors of mortality in ICU patients… but do they interact to associate w harm?
👀 at A Subramaniam et al’s new study, just out in #journal_CHESTCritCare, to find out:
www.chestcc.org/article/S294...
@accpchest.bsky.social
👀 at A Subramaniam et al’s new study, just out in #journal_CHESTCritCare, to find out:
www.chestcc.org/article/S294...
@accpchest.bsky.social
July 7, 2025 at 7:50 PM
Both delirium 😵💫 & frailty 🚫💪 are important predictors of mortality in ICU patients… but do they interact to associate w harm?
👀 at A Subramaniam et al’s new study, just out in #journal_CHESTCritCare, to find out:
www.chestcc.org/article/S294...
@accpchest.bsky.social
👀 at A Subramaniam et al’s new study, just out in #journal_CHESTCritCare, to find out:
www.chestcc.org/article/S294...
@accpchest.bsky.social